comparemela.com

Latest Breaking News On - Berlin institute of health center - Page 1 : comparemela.com

Pluri (PLUR) CEO Issues Letter to Shareholders

Pluri (PLUR) CEO Issues Letter to Shareholders
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Empagliflozin may reduce serum uric acid in HF patients, lower mortality risk: EMPEROR-reduced trial

Germany: In patients with heart failure, hyperuricemia is a common comorbidity and is an independent predictor of advanced disease severity and increased mortality, the researchers state in a study.

New study can help determine effectiveness of chemotherapy in patients with bladder cancer

New study can help determine effectiveness of chemotherapy in patients with bladder cancer In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body s immune system response to the malignancy. This is the conclusion of research conducted by a team of scientists from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health. The findings, which have been published in Science Translational Medicine, can be used to predict treatment success and may increase survival in patients with bladder cancer. Bladder cancer is one of the ten most common types of cancer in Germany, and one of the five most common cancers in men. Nationwide, the disease affects approximately 30,000 people a year. The risk of cancer spreading (metastasizing) is particularly high once it invades the muscle layer inside the bladder wall.

Bladder cancer -- When to use chemotherapy

 E-Mail IMAGE: The research team plans to study patients with bladder cancer and other cancers to establish whether cell therapy might be used to encourage and enhance the immune system s fight against. view more  Credit: Photo: Hirscher/Charité In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body s immune system response to the malignancy. This is the conclusion of research conducted by a team of scientists from Charité - Universitätsmedizin Berlin and the Berlin Institute of Health. The findings, which have been published in Science Translational Medicine , can be used to predict treatment success and may increase survival in patients with bladder cancer.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.